Literature DB >> 10461605

Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging.

M G Levine1, A W Ahlberg, A Mann, M P White, C C McGill, C Mendes de Leon, J M Piriz, D Waters, G V Heller.   

Abstract

PURPOSE: The purpose of this study was to compare defect extent and severity and myocardial uptake with exercise and pharmacologic stress with technetium-99m (Tc-99m) tetrofosmin tomographic myocardial perfusion imaging.
BACKGROUND: Detection of stress-induced myocardial perfusion defects depends on both a disparity in blood flow between normal and stenotic vessels and the extraction fraction and linearity of myocardial uptake of the tracer. There are limited clinical data for exercise or pharmacologic stress with Tc-99m tetrofosmin tomographic myocardial perfusion imaging.
METHODS: Thirty-one patients with coronary artery disease and 7 with a < 5% likelihood of coronary artery disease underwent on separate days Tc-99m tetrofosmin single-photon emission computed tomographic imaging at rest and after exercise, dipyridamole, adenosine, and dobutamine stress. Images were interpreted by a blinded consensus of 3 experienced readers with a 17-segment model and 5-point scoring system.
RESULTS: Compared with exercise, the summed stress score was smaller with dipyridamole (P < .01), and the reversibility score was smaller with both dipyridamole (P < .01) and dobutamine (P < .05), whereas the number of abnormal and reversible segments was less with both dipyridamole (P < .01 and P < .001, respectively) and dobutamine (both P < .05). No significant differences were found in the summed stress or reversibility scores and the number of abnormal or reversible segments between exercise and adenosine.
CONCLUSIONS: Compared with exercise, defect extent, severity, and reversibility are less with dipyridamole and dobutamine with Tc-99m tetrofosmin single photon emission computed tomographic imaging.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461605     DOI: 10.1016/s1071-3581(99)90004-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  30 in total

1.  Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease.

Authors:  H Shanoudy; P Raggi; G A Beller; A Soliman; E G Ammermann; R J Kastner; D D Watson
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

2.  Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease.

Authors:  J K Kahn; I McGhie; M S Akers; M N Sills; T L Faber; P V Kulkarni; J T Willerson; J R Corbett
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

3.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease.

Authors:  G A Diamond; J S Forrester
Journal:  N Engl J Med       Date:  1979-06-14       Impact factor: 91.245

4.  Assessing coronary artery disease with dipyridamole technetium-99m-tetrofosmin SPECT: a multicenter trial.

Authors:  Z X He; A S Iskandrian; N C Gupta; M S Verani
Journal:  J Nucl Med       Date:  1997-01       Impact factor: 10.057

5.  Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing.

Authors:  A Cuocolo; E Nicolai; A Soricelli; L Pace; A Nappi; P Sullo; S Cardei; L Argenziano; P J Ell; M Salvatore
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

6.  Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.

Authors:  D Jain; F J Wackers; J Mattera; M McMahon; A J Sinusas; B L Zaret
Journal:  J Nucl Med       Date:  1993-08       Impact factor: 10.057

7.  Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole.

Authors:  D K Glover; R D Okada
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

8.  Clinical comparison between thallium-201 and Tc-99m-methoxy isobutyl isonitrile (hexamibi) myocardial perfusion imaging for detection of coronary artery disease.

Authors:  R Taillefer; R Lambert; G Dupras; J Grégoire; J Léveillé; R Essiambre; D C Phaneuf
Journal:  Eur J Nucl Med       Date:  1989

9.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

10.  Comparison of dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery disease.

Authors:  S D Herman; K A LaBresh; C D Santos-Ocampo; C E Garber; M M Barbour; D E Messinger; D J Cloutier; A W Ahlberg; G V Heller
Journal:  Am J Cardiol       Date:  1994-01-15       Impact factor: 2.778

View more
  15 in total

1.  Pharmacologic stress testing: understanding the options.

Authors:  M P White
Journal:  J Nucl Cardiol       Date:  1999 Nov-Dec       Impact factor: 5.952

Review 2.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

3.  Direct comparison of adenosine and adenosine 5'-triphosphate as pharmacologic stress agents in conjunction with Tl-201 SPECT: Hemodynamic response, myocardial tracer uptake, and size of perfusion defects in the same subjects.

Authors:  Kyung Ah Chun; Jaetae Lee; Sang-Woo Lee; Byeong-Cheol Ahn; Jeoung-Hee Ha; Ihn Ho Cho; Shung Chull Chae; Kyu Bo Lee
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

4.  Differential effects of pharmacologic stressors: more than meets the eye.

Authors:  Philipp A Kaufmann
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

5.  "Mismatch" in regional myocardial perfusion defects during exercise and pharmacologic vasodilation: a noninvasive marker of epicardial vasomotor dysfunction?

Authors:  Thomas H Schindler; Heinrich H Schelbert
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

6.  Dobutamine technetium-99m tetrofosmin SPECT imaging for the diagnosis of coronary artery disease in patients with limited exercise capacity.

Authors:  A Elhendy; F B Sozzi; R Valkema; R T van Domburg; J J Bax; J R Roelandt
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

7.  Feasibility and diagnostic accuracy of exercise treadmill nitrogen-13 ammonia PET myocardial perfusion imaging of obese patients.

Authors:  Niti R Aggarwal; Adela Drozdova; J Wells Askew; Bradley J Kemp; Panithaya Chareonthaitawee
Journal:  J Nucl Cardiol       Date:  2015-03-17       Impact factor: 5.952

8.  Cardiac function changes with switching from the supine to prone position: analysis by quantitative semiconductor gated single-photon emission computed tomography.

Authors:  Masato Shimizu; Hiroyuki Fujii; Noriyoshi Yamawake; Mitsuhiro Nishizaki
Journal:  J Nucl Cardiol       Date:  2015-01-23       Impact factor: 5.952

9.  Larger perfusion defects with exercise compared with dipyridamole SPECT (exercise-dipyridamole mismatch) may reflect differences in epicardial and microvascular coronary dysfunction: when the stressor matters.

Authors:  Edoardo Verna; Luca Ceriani; Stefano Provasoli; Simone Scotti; Sergio Ghiringhelli
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

10.  Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT.

Authors:  Timothy M Bateman; Gary V Heller; A Iain McGhie; John D Friedman; James A Case; Jan R Bryngelson; Ginger K Hertenstein; Kelly L Moutray; Kimberly Reid; S James Cullom
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.